Clinical Trial Agreements (CTA)
CTAs are used to transfer an investigational agent for use in an NCI-sponsored clinical trial when no transfer of funds between the collaborator and NCI are involved.
To view a model CTA, click here.
Confidentiality Disclosure Agreements (CDA)
CDAs allow NCI scientists and outside parties to freely exchange confidential information. There are three different versions of the CDA:
To view a CDA for two parties sharing confidential information, click here.
To view a CDA for an outside party receiving confidential information from NIH,
To view a CDA for an outside party providing confidential information to NIH,
Cooperative Research and Development Agreements (CRADA)
CRADAs allow for the exchange of materials, personnel, and equipment between NCI scientists and non-governmental entities and may confer intellectual property rights.
To view a model CRADA, click here.
Simple Letter of Agreement (SLA)
SLAs allow research materials to be exchanged between NCI scientists and outside parties when intellectual property is not involved.
To view a model SLA, click here.